These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2432352)

  • 1. Sulfated glycosaminoglycans: a common constituent of all amyloids?
    Snow AD; Willmer J; Kisilevsky R
    Lab Invest; 1987 Jan; 56(1):120-3. PubMed ID: 2432352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
    Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
    Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.
    Snow AD; Mar H; Nochlin D; Kimata K; Kato M; Suzuki S; Hassell J; Wight TN
    Am J Pathol; 1988 Dec; 133(3):456-63. PubMed ID: 2974240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral amyloid angiopathy. Frequency, significance and immunohistochemistry.
    Sillus M; Saeger W; Linke RP; Müller D; Voigt C
    Zentralbl Pathol; 1993 Aug; 139(3):207-15. PubMed ID: 7692958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfated glycosaminoglycans in amyloid plaques of prion diseases.
    Snow AD; Kisilevsky R; Willmer J; Prusiner SB; DeArmond SJ
    Acta Neuropathol; 1989; 77(4):337-42. PubMed ID: 2523631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain.
    Czasch S; Paul S; Baumgärtner W
    Neurobiol Aging; 2006 Feb; 27(2):293-305. PubMed ID: 16002188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfated glycosaminoglycans in Alzheimer's disease.
    Snow AD; Willmer JP; Kisilevsky R
    Hum Pathol; 1987 May; 18(5):506-10. PubMed ID: 3570282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energy dispersive X-ray microanalysis of sulfated glycosaminoglycans in cartilage matrix stained with alcian blue 8GX.
    Módis L; Lustyik G; Adány R; Nagy I
    Basic Appl Histochem; 1988; 32(4):415-28. PubMed ID: 2464987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topo-optical visualization reactions of carbohydrate-containing amyloid deposits in the respiratory tract.
    Richter S; Makovitzky J
    Acta Histochem; 2006; 108(3):181-91. PubMed ID: 16542712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease: glycolytic pretreatment dramatically enhances immunolabeling of senile plaques and cerebrovascular amyloid substance.
    Behrouz N; Defossez A; Delacourte A; Hublau P; Mazzuca M
    Lab Invest; 1989 Nov; 61(5):576-83. PubMed ID: 2478759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with Congo red histochemical stain.
    Wilcock DM; Gordon MN; Morgan D
    Nat Protoc; 2006; 1(3):1591-5. PubMed ID: 17406451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody.
    Ikeda S; Allsop D; Glenner GG
    Lab Invest; 1989 Jan; 60(1):113-22. PubMed ID: 2642985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A close ultrastructural relationship between sulfated proteoglycans and AA amyloid fibrils.
    Snow AD; Willmer J; Kisilevsky R
    Lab Invest; 1987 Dec; 57(6):687-98. PubMed ID: 2447384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration.
    Glenner GG; Henry JH; Fujihara S
    Ann Pathol; 1981; 1(2):120-9. PubMed ID: 6169353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ultrastructural localization of sulfated proteoglycans is identical in the amyloids of Alzheimer's disease and AA, AL, senile cardiac and medullary carcinoma-associated amyloidosis.
    Young ID; Willmer JP; Kisilevsky R
    Acta Neuropathol; 1989; 78(2):202-9. PubMed ID: 2473595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid beta-protein in cerebral amyloid angiopathy, senile plaques, and preamyloidotic lesions in subcortical arteriosclerotic encephalopathy (Binswanger disease).
    Guiroy DC; Bogucki A; Papierz W; Liberski PP; Yanagihara R
    Neurosci Lett; 1991 Mar; 124(1):31-4. PubMed ID: 1857541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactive calcitonin in amyloid fibrils of medullary carcinoma of the thyroid gland. An immunogold staining technique.
    Butler M; Khan S
    Arch Pathol Lab Med; 1986 Jul; 110(7):647-9. PubMed ID: 2424399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical evidence for the lack of amyloid P component in some intracerebral amyloids.
    Westermark P; Shirahama T; Skinner M; Brun A; Cameron R; Cohen AS
    Lab Invest; 1982 May; 46(5):457-60. PubMed ID: 7043084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical identification and cross reactions of amyloid fibril proteins in senile heart and amyloid in familial polyneuropathy. Lack of reactivity with cerebral amyloid in Alzheimer's disease.
    Linke RP
    Clin Neuropathol; 1982; 1(4):172-82. PubMed ID: 6301727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-34 labeling of abnormal protein aggregates during the progression of Alzheimer's disease.
    Ikonomovic MD; Abrahamson EE; Isanski BA; Debnath ML; Mathis CA; Dekosky ST; Klunk WE
    Methods Enzymol; 2006; 412():123-44. PubMed ID: 17046656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.